Kaleido news
10 May 2016

Remmert Laan joins ViCentra’s Board

ViCentra today announced that Remmert Laan, President of specialist diabetes consultancy, Diabetes Insights, LLC, has joined the ViCentra Board as a Non-executive Board Member.

Prior to launching Diabetes Insights, LLC in 2015, Rem held the position of Executive Director of the William Sansum Diabetes Center in California. He has more than 15 years’ experience in the commercialisation of diabetes devices, including insulin pump products, having previously served as Vice President, External Affairs, North America and Vice President, Insulin Delivery Systems Global Marketing and Reimbursement for Roche Diabetes Care.

“Rem has an incredible wealth of expert knowledge of the diabetes market and we are delighted to welcome him to ViCentra’s Board,” said Michael Graves, ViCentra’s CEO. “As we move closer to the European launch of our first product, Kaleido, a game-changing insulin delivery system, we believe Rem’s understanding of the market and his belief that the customer should always be put first is the perfect fit for us”.

“I am very pleased to be joining the Board of ViCentra at such an exciting time for the company,” said Rem Laan. “Their unique approach to creating healthcare products – designing for people, not patients – is one I admire. And it works – the Kaleido insulin pump is like no other and has the potential to significantly broaden the market for this life changing therapy for people with diabetes.”

Laan holds an MBA from the Tuck School at Dartmouth College and a BA in Economics from Carleton College. He is also the inventor of Accu-Chek’s 360° View System – a simple way to determine the right drug, dose and timing for optimal blood sugar control – and was an early pioneer in the field of mHealth.